ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 710525 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 710525; 2) Community: the network communities that were significantly associated with the response to NSC 710525; 3) Molecule: the relationships between components within communities and NSC 710525; 4) MDR: the compounds that were significantly associated with the NSC 710525.

NSC Compound Enrichment Correlation
NSC 686554 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- 0.0212053315848709 0.34976402
NSC 6926 Null 0.0212053315848709 0.3861476
NSC 712572 1,2 Benzo-8-(1-hydroxy-2-methylamino propane)-3-phenoxazone 0.0212053315848711 0.21489941
NSC 715407 Null 0.0212053315848711 0.32311565
NSC 718781 Erlotinib hydrochloride 0.0212053315848711 -0.20686038
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0212053315848711 -0.0041841135
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0212053315848711 0.33401952
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0212053315848711 0.19937005
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0212053315848711 0.34263238
NSC 742036 Null 0.0212053315848711 -0.022188754
Total:90  Current:40    [First] [Prev] [Next] [Last]